All anti obesity medications including semaglutide, tirzepatide, and liraglutide, may carry gastrointestinal adverse events such as abdominal pain, decreased appetite, and nausea, and they should be used under close medical supervision, particularly in individuals with a family medical history of thyroid cancer, or existing cardiovascular disease, chronic kidney disease, or risk of heart attack
Factors like your medical history, potential side effects, insurance coverage, and how your body responds to treatment all play a role
A research study looking at how oral semaglutide works in people with type 2 diabetes in the United Kingdom, as part of local clinical practice (PIONEER REAL)
It needs to stay between 2C and 8C (36F and 46F), so check your fridge settings first
Weeks 1-4 : 2.5mg Weeks 5-8 : 5mg *maintenance dose solely for weight reduction Weeks 9-12: 7.5mg Weeks 13-16 : 10 mg *recommended maintenance dose for all indications Weeks 17-20: 12.5mg Weeks 21+ : 15mg *maintenance dose all indications Personalized GLP-1 Weight-Loss Support Take a short assessment to explore whether semaglutide or tirzepatide could fit your weight-loss goals and what a starting approach may look like
Rotating injection spots can help reduce the chances of this happening repeatedly in the same area